Calamos Advisors’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $39.1M | Sell |
|
|||||
|
2022
Q4 | $37.1M | Sell |
|
|||||
|
2022
Q3 | $32.7M | Sell |
|
|||||
|
2022
Q2 | $42.3M | Buy |
|
|||||
|
2022
Q1 | $44.9M | Sell |
|
|||||
|
2021
Q4 | $44.6M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $53M | Sell |
|
|||||
|
2020
Q3 | $61.9M | Sell |
|
|||||
|
2020
Q2 | $59.7M | Buy |
|